Moderate Aortic Stenosis: Pathophysiology, Diagnostic Criteria, Prognosis and Evolving Management

Aortic stenosis (AS) is a progressive valvular disease with rising incidence, particularly among elderly populations. Although excess mortality in severe AS is well recognised, moderate AS is also associated with significant morbidity and mortality. Current guidelines recommend valve replacement only for severe AS or in moderate AS with a concomitant surgical indication, leaving a therapeutic gap. This review summarises current knowledge on the epidemiology, pathophysiology, natural history and diagnostic challenges of AS management, with an emphasis on moderate disease. We discuss prognostic markers, including myocardial fibrosis, reduced left ventricular ejection fraction, global longitudinal strain and autonomic dysfunction, that may identify high-risk moderate AS patients. Evidence from recent and ongoing trials of transcatheter aortic valve replacement and novel pharmacotherapies is summarised, and limitations of existing valve prostheses and medical therapies are discussed. Improved risk stratification, earlier detection of pathological changes and targeted intervention may ultimately improve the management paradigm for moderate AS.

Authors

Institutions

Publication Details

Journal
European Cardiology Review
Published
2026-11-16
DOI
https://doi.org/10.15420/ecr.2025.78
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Moderate Aortic Stenosis: Pathophysiology, Diagnostic Criteria, Prognosis and Evolving Management

Andrew O Maree, Rose Anne Kenny, Mark Hensey, Jack Hartnett et al.
European Cardiology Review
Cardiac Valve Diseases and Treatments
article

Moderate Aortic Stenosis: Pathophysiology, Diagnostic Criteria, Prognosis and Evolving Management

Andrew O Maree, Rose Anne Kenny, Mark Hensey, Jack Hartnett, Caroline Daly, Niall Patrick Connolly, Stephen O’Connor
article en

Abstract

Aortic stenosis (AS) is a progressive valvular disease with rising incidence, particularly among elderly populations. Although excess mortality in severe AS is well recognised, moderate AS is also associated with significant morbidity and mortality. Current guidelines recommend valve replacement only for severe AS or in moderate AS with a concomitant surgical indication, leaving a therapeutic gap. This review summarises current knowledge on the epidemiology, pathophysiology, natural history and diagnostic challenges of AS management, with an emphasis on moderate disease. We discuss prognostic markers, including myocardial fibrosis, reduced left ventricular ejection fraction, global longitudinal strain and autonomic dysfunction, that may identify high-risk moderate AS patients. Evidence from recent and ongoing trials of transcatheter aortic valve replacement and novel pharmacotherapies is summarised, and limitations of existing valve prostheses and medical therapies are discussed. Improved risk stratification, earlier detection of pathological changes and targeted intervention may ultimately improve the management paradigm for moderate AS.

European Cardiology Review
Trinity College Dublin (IE), St. James's Hospital (IE)
Good health and well-being
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon